FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Attorneys Discuss New FDA Draft NCI Guidance

Two Axinn attorneys explain a new FDA draft guidance on new clinical investigation exclusivity and ways that some NDA and sNDA applicants may be able ...

latest-news-card-1
Human Drugs

Continue Modernizing Foreign Inspections: Study

Academic researchers call on FDA to continue to modernize its foreign drug inspection program and overcome differences in inspection intensity between...

latest-news-card-1
Medical Devices

FDA Draft Guidance for Medical Devices Intended for Weight Loss

FDA posts a draft guidance entitled Medical Devices with Indications Associated with Weight Loss - Premarket Considerations.

latest-news-card-1

AI Has Saved FDA 17,000 Hours: Makary

FDA commissioner Marty Makary explains how the agency is using AI to modernize tedious tasks performed by humans to make drug reviews more efficient a...

latest-news-card-1
Biologics

FDA Panel Backs Trivalent Influenza Vaccine for 2027 Season

FDAs Vaccines and Related Biological Products Advisory Committee votes to recommend that seasonal influenza vaccines for the 20262027 U.S. season use ...

latest-news-card-1
Human Drugs

FDA Posts 483 Related to New Novo Nordisk Warning Letter

FDA releases the Form 483 behind a 3/5 Warning Letter to Novo Nordisk that cited serious violations of postmarketing adverse drug experience reporting...

latest-news-card-1
Human Drugs

CGMP Violations in Tentamus India Inspection

FDA warns Indias Tentamus India Private Limited contract laboratory about significant violations of CGMP regulations.

latest-news-card-1
Medical Devices

Advita Ortho Hit with 7 QS Violations

FDA warns Exactech, doing business as Advita Ortho, about Quality System violations in its production of accessories for the Equinoxe Reverse Shoulder...

latest-news-card-1
Human Drugs

Rosemont Pharma Gets Complete Response on Valacyclovir

FDA posts a 3/5 complete response letter to Rosemont Pharmaceuticals, rejecting the companys NDA for valacyclovir.

latest-news-card-1
Human Drugs

Sen. Johnson Probing FDA Rare Disease Denials

Senator Ron Johnson (R-WI) launches a congressional investigation into FDAs recent decisions to reject or delay treatments for rare diseases.